Stock screener

MAZE

Conviction 12HealthcareScan · Thu, Sep 24, 2026

Maze Therapeutics, Inc. (MAZE) closed at $26.23 (-6.62%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 50, RS Rating 75, -49.4% from its 52-week high, -34.1% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

MAZE$26.23-6.62%
ResistanceSupportVol 14Insider sell
63 bars
4
Vol MA14 959.8K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Maze Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.mazetx.com ↗
Price26.23
Change-6.62%
Gap+1.17%
Rel volume1.45×
Avg volume805.91K
Avg $ vol21.03M
SMA 2025.61
SMA 5027.18
SMA 20033.38
Price vs 50-3.50%
Price vs 200-21.42%
MA stackbearish
50/200 cross—
Supertrendup · 22.85
RSI (14)50
MACD hist0.32
MACD crossbull · 2d
Stoch %K / %D54 / 72
ADX (14)26
+DI / −DI29 / 23
RSI divergence—
MACD divergenceBullish
ATR %7.09%
ADR %6.20%
52w high51.84
52w low22.39
From 52w high-49.40%
Above 52w low+17.15%
New 52w highNo
SqueezeOff
Bollinger width27.83%
%B0.59
Donchian pos53.77%
Donchian high29.91
Donchian low21.95
AVWAP (52w high)29.17
vs AVWAP high-10.09%
AVWAP (52w low)27.24
vs AVWAP low-3.70%
OBV trendDown
Chaikin MF (20)-0.13
Today vs 20d1.45×
Avg vol (14d)959.8K
Avg vol (20d)805.91K
Avg $ vol (20d)21.03M
Market cap1.46B
RS Rating75 / 99
RS 3m (vs SPY)-7.42%
RS 6m (vs SPY)-34.15%
RS line new highNo
Trend template0/8
Technical rank26.6
1 week+11.90%
1 month-13.77%
3 months-2.92%
6 months-17.33%
1 year+5.43%
YTD-34.05%
P/E-11.11
P/B3.22
P/S8.70
P/FCF-12.92
EPS-3.05
Div yield—
ROE-28.94%
ROA-24.66%
Debt/Eq0.09
Current18.31
EV/EBITDA—
Gross margin—
Net margin-78.28%
Rev growth—
EPS growth-351.04%
Price target61.43
Target upside134.20%
Analyst ratingBuy
Institutional111.08%
Ent. value1.29B
Revenue20M
Net income-44.73M
Gross profit—
Free cash flow-112.73M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out55.35M
Employees141
ListedFri, Jan 31, 2025
Free float28.18M
Float %58.6%
Short interest5.92M
Days to cover16.1d
Short volume67.5%
Squeeze score90 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.76 vs −$0.76
Last surprise0.0% beat
Setup gradeD
Conviction12 / 100
Pattern quality—
Tech rank26.6 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance30.49
Support22.95
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MAZE

All disclosures →
No recent disclosed trades by Congress in MAZE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MAZE · open-market 4 sells

InsiderSideShares
Bernstein Harold
President, R&D & CMO · Common Stock · 2026-09-04
Sell9.71K
Dandekar Atul
CSBO · Common Stock · 2026-08-28
Sell7.5K
Dandekar Atul
CSBO · Common Stock · 2026-08-28
Exercise7.5K
Dandekar Atul
CSBO · Stock Option (Right to Buy) · 2026-08-28
Exercise7.5K
Johnson Paula A
Director · Stock Option (Right to Buy) · 2026-08-13
Grant36K
Kornowski Sophie
Director · Stock Option (Right to Buy) · 2026-08-13
Grant36K
Bernstein Harold
President, R&D & CMO · Stock Option (Right to Buy) · 2026-08-13
Exercise16.14K
Bernstein Harold
President, R&D & CMO · Common Stock · 2026-08-13
Exercise16.14K
Bernstein Harold
President, R&D & CMO · Common Stock · 2026-08-13
Sell16.14K
Coloma Jason V
Chief Executive Officer · Common Stock · 2026-08-03
Sell1.6K

SEC filings

EDGAR filings in MAZE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.